Copyright Reports & Markets. All rights reserved.

Global Animal Parvovirus Vaccine Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Animal Parvovirus Vaccine Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Individual Vaccine
    • 1.3.3 Combination Vaccine
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Animal Parvovirus Vaccine Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Porcine
    • 1.4.3 Canine
    • 1.4.4 Feline
    • 1.4.5 Others
  • 1.5 Global Animal Parvovirus Vaccine Market Size & Forecast
    • 1.5.1 Global Animal Parvovirus Vaccine Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Animal Parvovirus Vaccine Sales Quantity (2021-2032)
    • 1.5.3 Global Animal Parvovirus Vaccine Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Boehringer Ingelheim
    • 2.1.1 Boehringer Ingelheim Details
    • 2.1.2 Boehringer Ingelheim Major Business
    • 2.1.3 Boehringer Ingelheim Animal Parvovirus Vaccine Product and Services
    • 2.1.4 Boehringer Ingelheim Animal Parvovirus Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Boehringer Ingelheim Recent Developments/Updates
  • 2.2 Zoetis
    • 2.2.1 Zoetis Details
    • 2.2.2 Zoetis Major Business
    • 2.2.3 Zoetis Animal Parvovirus Vaccine Product and Services
    • 2.2.4 Zoetis Animal Parvovirus Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Zoetis Recent Developments/Updates
  • 2.3 Merck Animal Health
    • 2.3.1 Merck Animal Health Details
    • 2.3.2 Merck Animal Health Major Business
    • 2.3.3 Merck Animal Health Animal Parvovirus Vaccine Product and Services
    • 2.3.4 Merck Animal Health Animal Parvovirus Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Merck Animal Health Recent Developments/Updates
  • 2.4 HIPRA
    • 2.4.1 HIPRA Details
    • 2.4.2 HIPRA Major Business
    • 2.4.3 HIPRA Animal Parvovirus Vaccine Product and Services
    • 2.4.4 HIPRA Animal Parvovirus Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 HIPRA Recent Developments/Updates
  • 2.5 Ceva Animal Health
    • 2.5.1 Ceva Animal Health Details
    • 2.5.2 Ceva Animal Health Major Business
    • 2.5.3 Ceva Animal Health Animal Parvovirus Vaccine Product and Services
    • 2.5.4 Ceva Animal Health Animal Parvovirus Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Ceva Animal Health Recent Developments/Updates
  • 2.6 Bioveta
    • 2.6.1 Bioveta Details
    • 2.6.2 Bioveta Major Business
    • 2.6.3 Bioveta Animal Parvovirus Vaccine Product and Services
    • 2.6.4 Bioveta Animal Parvovirus Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Bioveta Recent Developments/Updates
  • 2.7 Elanco
    • 2.7.1 Elanco Details
    • 2.7.2 Elanco Major Business
    • 2.7.3 Elanco Animal Parvovirus Vaccine Product and Services
    • 2.7.4 Elanco Animal Parvovirus Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Elanco Recent Developments/Updates
  • 2.8 Virbac
    • 2.8.1 Virbac Details
    • 2.8.2 Virbac Major Business
    • 2.8.3 Virbac Animal Parvovirus Vaccine Product and Services
    • 2.8.4 Virbac Animal Parvovirus Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Virbac Recent Developments/Updates
  • 2.9 Ringpu Bio-technology
    • 2.9.1 Ringpu Bio-technology Details
    • 2.9.2 Ringpu Bio-technology Major Business
    • 2.9.3 Ringpu Bio-technology Animal Parvovirus Vaccine Product and Services
    • 2.9.4 Ringpu Bio-technology Animal Parvovirus Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Ringpu Bio-technology Recent Developments/Updates
  • 2.10 Keqian Biology
    • 2.10.1 Keqian Biology Details
    • 2.10.2 Keqian Biology Major Business
    • 2.10.3 Keqian Biology Animal Parvovirus Vaccine Product and Services
    • 2.10.4 Keqian Biology Animal Parvovirus Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Keqian Biology Recent Developments/Updates
  • 2.11 China Animal Husbandy Industry
    • 2.11.1 China Animal Husbandy Industry Details
    • 2.11.2 China Animal Husbandy Industry Major Business
    • 2.11.3 China Animal Husbandy Industry Animal Parvovirus Vaccine Product and Services
    • 2.11.4 China Animal Husbandy Industry Animal Parvovirus Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 China Animal Husbandy Industry Recent Developments/Updates
  • 2.12 Qilu Animal Health Products
    • 2.12.1 Qilu Animal Health Products Details
    • 2.12.2 Qilu Animal Health Products Major Business
    • 2.12.3 Qilu Animal Health Products Animal Parvovirus Vaccine Product and Services
    • 2.12.4 Qilu Animal Health Products Animal Parvovirus Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Qilu Animal Health Products Recent Developments/Updates
  • 2.13 DHN
    • 2.13.1 DHN Details
    • 2.13.2 DHN Major Business
    • 2.13.3 DHN Animal Parvovirus Vaccine Product and Services
    • 2.13.4 DHN Animal Parvovirus Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 DHN Recent Developments/Updates
  • 2.14 Harbin Pharmaceutical Group
    • 2.14.1 Harbin Pharmaceutical Group Details
    • 2.14.2 Harbin Pharmaceutical Group Major Business
    • 2.14.3 Harbin Pharmaceutical Group Animal Parvovirus Vaccine Product and Services
    • 2.14.4 Harbin Pharmaceutical Group Animal Parvovirus Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Harbin Pharmaceutical Group Recent Developments/Updates
  • 2.15 Hile Biological
    • 2.15.1 Hile Biological Details
    • 2.15.2 Hile Biological Major Business
    • 2.15.3 Hile Biological Animal Parvovirus Vaccine Product and Services
    • 2.15.4 Hile Biological Animal Parvovirus Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Hile Biological Recent Developments/Updates
  • 2.16 Pulike Biological
    • 2.16.1 Pulike Biological Details
    • 2.16.2 Pulike Biological Major Business
    • 2.16.3 Pulike Biological Animal Parvovirus Vaccine Product and Services
    • 2.16.4 Pulike Biological Animal Parvovirus Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.16.5 Pulike Biological Recent Developments/Updates

3 Competitive Environment: Animal Parvovirus Vaccine by Manufacturer

  • 3.1 Global Animal Parvovirus Vaccine Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Animal Parvovirus Vaccine Revenue by Manufacturer (2021-2026)
  • 3.3 Global Animal Parvovirus Vaccine Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Animal Parvovirus Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Animal Parvovirus Vaccine Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Animal Parvovirus Vaccine Manufacturer Market Share in 2025
  • 3.5 Animal Parvovirus Vaccine Market: Overall Company Footprint Analysis
    • 3.5.1 Animal Parvovirus Vaccine Market: Region Footprint
    • 3.5.2 Animal Parvovirus Vaccine Market: Company Product Type Footprint
    • 3.5.3 Animal Parvovirus Vaccine Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Animal Parvovirus Vaccine Market Size by Region
    • 4.1.1 Global Animal Parvovirus Vaccine Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Animal Parvovirus Vaccine Consumption Value by Region (2021-2032)
    • 4.1.3 Global Animal Parvovirus Vaccine Average Price by Region (2021-2032)
  • 4.2 North America Animal Parvovirus Vaccine Consumption Value (2021-2032)
  • 4.3 Europe Animal Parvovirus Vaccine Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Animal Parvovirus Vaccine Consumption Value (2021-2032)
  • 4.5 South America Animal Parvovirus Vaccine Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Animal Parvovirus Vaccine Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Animal Parvovirus Vaccine Sales Quantity by Type (2021-2032)
  • 5.2 Global Animal Parvovirus Vaccine Consumption Value by Type (2021-2032)
  • 5.3 Global Animal Parvovirus Vaccine Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Animal Parvovirus Vaccine Sales Quantity by Application (2021-2032)
  • 6.2 Global Animal Parvovirus Vaccine Consumption Value by Application (2021-2032)
  • 6.3 Global Animal Parvovirus Vaccine Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Animal Parvovirus Vaccine Sales Quantity by Type (2021-2032)
  • 7.2 North America Animal Parvovirus Vaccine Sales Quantity by Application (2021-2032)
  • 7.3 North America Animal Parvovirus Vaccine Market Size by Country
    • 7.3.1 North America Animal Parvovirus Vaccine Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Animal Parvovirus Vaccine Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Animal Parvovirus Vaccine Sales Quantity by Type (2021-2032)
  • 8.2 Europe Animal Parvovirus Vaccine Sales Quantity by Application (2021-2032)
  • 8.3 Europe Animal Parvovirus Vaccine Market Size by Country
    • 8.3.1 Europe Animal Parvovirus Vaccine Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Animal Parvovirus Vaccine Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Animal Parvovirus Vaccine Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Animal Parvovirus Vaccine Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Animal Parvovirus Vaccine Market Size by Region
    • 9.3.1 Asia-Pacific Animal Parvovirus Vaccine Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Animal Parvovirus Vaccine Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Animal Parvovirus Vaccine Sales Quantity by Type (2021-2032)
  • 10.2 South America Animal Parvovirus Vaccine Sales Quantity by Application (2021-2032)
  • 10.3 South America Animal Parvovirus Vaccine Market Size by Country
    • 10.3.1 South America Animal Parvovirus Vaccine Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Animal Parvovirus Vaccine Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Animal Parvovirus Vaccine Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Animal Parvovirus Vaccine Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Animal Parvovirus Vaccine Market Size by Country
    • 11.3.1 Middle East & Africa Animal Parvovirus Vaccine Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Animal Parvovirus Vaccine Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Animal Parvovirus Vaccine Market Drivers
  • 12.2 Animal Parvovirus Vaccine Market Restraints
  • 12.3 Animal Parvovirus Vaccine Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Animal Parvovirus Vaccine and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Animal Parvovirus Vaccine
  • 13.3 Animal Parvovirus Vaccine Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Animal Parvovirus Vaccine Typical Distributors
  • 14.3 Animal Parvovirus Vaccine Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Animal Parvovirus Vaccine market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    This report is a detailed and comprehensive analysis for global Animal Parvovirus Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Animal Parvovirus Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (Dose), and average selling prices (US$/Dose), 2021-2032
    Global Animal Parvovirus Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Dose), and average selling prices (US$/Dose), 2021-2032
    Global Animal Parvovirus Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Dose), and average selling prices (US$/Dose), 2021-2032
    Global Animal Parvovirus Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (Dose), and ASP (US$/Dose), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Animal Parvovirus Vaccine
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Animal Parvovirus Vaccine market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Boehringer Ingelheim, Zoetis, Merck Animal Health, HIPRA, Ceva Animal Health, Bioveta, Elanco, Virbac, Ringpu Bio-technology, Keqian Biology, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Animal Parvovirus Vaccine market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Individual Vaccine
    Combination Vaccine
    Market segment by Application
    Porcine
    Canine
    Feline
    Others
    Major players covered
    Boehringer Ingelheim
    Zoetis
    Merck Animal Health
    HIPRA
    Ceva Animal Health
    Bioveta
    Elanco
    Virbac
    Ringpu Bio-technology
    Keqian Biology
    China Animal Husbandy Industry
    Qilu Animal Health Products
    DHN
    Harbin Pharmaceutical Group
    Hile Biological
    Pulike Biological
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Animal Parvovirus Vaccine product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Animal Parvovirus Vaccine, with price, sales quantity, revenue, and global market share of Animal Parvovirus Vaccine from 2021 to 2026.
    Chapter 3, the Animal Parvovirus Vaccine competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Animal Parvovirus Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Animal Parvovirus Vaccine market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Animal Parvovirus Vaccine.
    Chapter 14 and 15, to describe Animal Parvovirus Vaccine sales channel, distributors, customers, research findings and conclusion.

    Buy now